Show simple item record

dc.contributor.authorDinnes, Jacqueline
dc.contributor.authorDeeks, Jonathan J
dc.contributor.authorGrainge, Matthew J
dc.contributor.authorChuchu, Naomi
dc.contributor.authorFerrante di Ruffano, Lavinia
dc.contributor.authorMatin, Rubeta N
dc.contributor.authorThomson, David R
dc.contributor.authorWong, Kai Yuen
dc.contributor.authorAldridge, Roger Benjamin
dc.contributor.authorAbbott, Rachel
dc.contributor.authorFawzy, Monica
dc.contributor.authorBayliss, Susan E
dc.contributor.authorTakwoingi, Yemisi
dc.contributor.authorDavenport, Clare
dc.contributor.authorGodfrey, Kathie
dc.contributor.authorWalter, Fiona
dc.contributor.authorWilliams, Hywel C
dc.contributor.authorCochrane Skin Cancer Diagnostic Test Accuracy Group
dc.date.accessioned2018-11-27T14:32:17Z
dc.date.available2018-11-27T14:32:17Z
dc.date.issued2018-12-04
dc.identifier.issn1469-493X
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/286003
dc.description.abstractBACKGROUND: Melanoma has one of the fastest rising incidence rates of any cancer. It accounts for a small percentage of skin cancer cases but is responsible for the majority of skin cancer deaths. History-taking and visual inspection of a suspicious lesion by a clinician is usually the first in a series of 'tests' to diagnose skin cancer. Establishing the accuracy of visual inspection alone is critical to understating the potential contribution of additional tests to assist in the diagnosis of melanoma. OBJECTIVES: To determine the diagnostic accuracy of visual inspection for the detection of cutaneous invasive melanoma and atypical intraepidermal melanocytic variants in adults with limited prior testing and in those referred for further evaluation of a suspicious lesion. Studies were separated according to whether the diagnosis was recorded face-to-face (in-person) or based on remote (image-based) assessment. SEARCH METHODS: We undertook a comprehensive search of the following databases from inception up to August 2016: CENTRAL; CINAHL; CPCI; Zetoc; Science Citation Index; US National Institutes of Health Ongoing Trials Register; NIHR Clinical Research Network Portfolio Database; and the World Health Organization International Clinical Trials Registry Platform. We studied reference lists and published systematic review articles. SELECTION CRITERIA: Test accuracy studies of any design that evaluated visual inspection in adults with lesions suspicious for melanoma, compared with a reference standard of either histological confirmation or clinical follow-up. We excluded studies reporting data for 'clinical diagnosis' where dermoscopy may or may not have been used. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted all data using a standardised data extraction and quality assessment form (based on QUADAS-2). We contacted authors of included studies where information related to the target condition or diagnostic threshold were missing. We estimated summary sensitivities and specificities per algorithm and threshold using the bivariate hierarchical model. We investigated the impact of: in-person test interpretation; use of a purposely developed algorithm to assist diagnosis; and observer expertise. MAIN RESULTS: We included 49 publications reporting on a total of 51 study cohorts with 34,351 lesions (including 2499 cases), providing 134 datasets for visual inspection. Across almost all study quality domains, the majority of study reports provided insufficient information to allow us to judge the risk of bias, while in three of four domains that we assessed we scored concerns regarding applicability of study findings as 'high'. Selective participant recruitment, lack of detail regarding the threshold for deciding on a positive test result, and lack of detail on observer expertise were particularly problematic.Attempts to analyse studies by degree of prior testing were hampered by a lack of relevant information and by the restricted inclusion of lesions selected for biopsy or excision. Accuracy was generally much higher for in-person diagnosis compared to image-based evaluations (relative diagnostic odds ratio of 8.54, 95% CI 2.89 to 25.3, P < 0.001). Meta-analysis of in-person evaluations that could be clearly placed on the clinical pathway showed a general trade-off between sensitivity and specificity, with the highest sensitivity (92.4%, 95% CI 26.2% to 99.8%) and lowest specificity (79.7%, 95% CI 73.7% to 84.7%) observed in participants with limited prior testing (n = 3 datasets). Summary sensitivities were lower for those referred for specialist assessment but with much higher specificities (e.g. sensitivity 76.7%, 95% CI 61.7% to 87.1%) and specificity 95.7%, 95% CI 89.7% to 98.3%) for lesions selected for excision, n = 8 datasets). These differences may be related to differences in the spectrum of included lesions, differences in the definition of a positive test result, or to variations in observer expertise. We did not find clear evidence that accuracy is improved by the use of any algorithm to assist diagnosis in all settings. Attempts to examine the effect of observer expertise in melanoma diagnosis were hindered due to poor reporting. AUTHORS' CONCLUSIONS: Visual inspection is a fundamental component of the assessment of a suspicious skin lesion; however, the evidence suggests that melanomas will be missed if visual inspection is used on its own. The evidence to support its accuracy in the range of settings in which it is used is flawed and very poorly reported. Although published algorithms do not appear to improve accuracy, there is insufficient evidence to suggest that the 'no algorithm' approach should be preferred in all settings. Despite the volume of research evaluating visual inspection, further prospective evaluation of the potential added value of using established algorithms according to the prior testing or diagnostic difficulty of lesions may be warranted.
dc.description.sponsorshipNIHR
dc.format.mediumElectronic
dc.languageeng
dc.publisherWiley
dc.subjectCochrane Skin Cancer Diagnostic Test Accuracy Group
dc.subjectHumans
dc.subjectMelanoma
dc.subjectSkin Neoplasms
dc.subjectDiagnostic Errors
dc.subjectPhysical Examination
dc.subjectSensitivity and Specificity
dc.subjectAlgorithms
dc.subjectAdult
dc.subjectAged
dc.subjectMiddle Aged
dc.titleVisual inspection for diagnosing cutaneous melanoma in adults.
dc.typeArticle
prism.publicationDate2018
prism.publicationNameCochrane Database Syst Rev
prism.startingPageCD013194
prism.volume12
dc.identifier.doi10.17863/CAM.33323
dcterms.dateAccepted2018-07-02
rioxxterms.versionofrecord10.1002/14651858.CD013194
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-12-04
dc.contributor.orcidWalter, Fiona [0000-0002-7191-6476]
dc.identifier.eissn1469-493X
rioxxterms.typeJournal Article/Review
cam.issuedOnline2018-12-04
rioxxterms.freetoread.startdate2019-12-03


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record